TrialLeukemia2022
Phase 2 study of oral thalidomide-cyclophosphamide-dexamethasone for recurrent/refractory adult Langerhans cell histiocytosis.
Ji-Nuo Wang et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
10 papers cite it
this papertrialcites it